Plain-English translation of NCT06714097 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a smartphone app called STRATIF-AI that uses artificial intelligence technology to help people prevent another stroke after they've already had one, or who have rare brain conditions like moyamoya disease or cerebral amyloid angiopathy. The app helps you understand your personal risk factors—like blood pressure—and shows you how lifestyle changes can make a difference. Half of the participants will use this app alongside their regular medical care, while the other half will receive standard care alone.
After a stroke or with certain rare brain conditions, patients need to make important lifestyle and medical changes to prevent future problems. This trial exists to see if a personalized app that explains why these changes matter and tracks your progress can help people stay healthier and more engaged in their own care.
You likely qualify if…
You likely don't qualify if…
You will visit the hospital twice—once at the start and once 6 months later. At each visit, you'll complete some thinking tests, answer questions about your health and mood, and provide information about how you're doing. If you're in the app group, you'll spend an extra 30 minutes learning how to use the STRATIF-AI app on your smartphone, then you can use it whenever you want to help manage your health and set personal goals. The app can also connect to wearable devices like fitness trackers if you have them.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
Italy